ELEVANCE HEALTH INC (ELV) Stock Analyst Ratings
USA - NYSE:ELV - US0367521038 - Common Stock
345.21 USD
-4.54 (-1.3%)
340.93 USD
-4.28 (-1.24%)
ChartMill assigns a Buy % Consensus number of 76% to ELV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 373.55. This target is 8.21% above the current price.
ELV was analyzed by 28 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ELV.
In the previous month the buy percentage consensus was at a similar level.
ELV was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-14 | Goldman Sachs | Initiate | Neutral |
| 2025-10-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-10 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-05 | UBS | Maintains | Buy -> Buy |
| 2025-09-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-25 | Baird | Maintains | Neutral -> Neutral |
| 2025-07-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-21 | Argus Research | Downgrade | Buy -> Hold |
| 2025-07-18 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-07-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-18 | UBS | Maintains | Buy -> Buy |
| 2025-07-18 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-14 | UBS | Maintains | Buy -> Buy |
| 2025-07-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-09 | Truist Securities | Maintains | Buy -> Buy |
| 2025-06-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-06-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-23 | Guggenheim | Reiterate | Buy -> Buy |